000013397 000__ 01349cam\a22003855i\4500
000013397 001__ 13397
000013397 003__ SzGeWIPO
000013397 005__ 20210318092600.0
000013397 008__ 040716s2002\\\\xx\\\\\\r\\\\u000\0\eng\d
000013397 035__ $$a(wipo)(CD )04-0252
000013397 035__ $$a(OCoLC)1160232682
000013397 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000013397 084__ $$aF 191 MEL.I
000013397 090__ $$c14102$$d14102
000013397 1001_ $$aMetlzer, Steven L.,$$eauthor.
000013397 24510 $$aIntellectual property as a foundation for funding /$$cSteven L. Metlzer.
000013397 264_1 $$a[Place of publication not identified] :$$b[publisher not identified],$$c2002.
000013397 300__ $$a4 pages ;$$c[28] cm
000013397 336__ $$atext$$btxt$$2rdacontent
000013397 337__ $$aunmediated$$bn$$2rdamedia
000013397 338__ $$avolume$$bnc$$2rdacarrier
000013397 500__ $$aArticle from the Volume 20 supplement to the journal Nature Biotechnology, 2002. See also : http://biotech.nature.com.
000013397 650_0 $$aIntellectual property.
000013397 650_0 $$aBiotechnology.
000013397 650_4 $$aVALUE OF INTELLECTUAL PROPERTY
000013397 650_4 $$aBIOTECHNOLOGY
000013397 650_4 $$aTECHNOLOGY
000013397 650_4 $$aRESEARCH AND DEVELOPMENT (R&D)
000013397 650_4 $$aBUSINESS TRANSACTIONS : INTELLECTUAL PROPERTY ISSUES
000013397 7001_ $$aMarks, Michelle S.
000013397 7001_ $$aMccormick, James T.
000013397 903__ $$v1
000013397 942__ $$cMON
000013397 952__ $$w2006-11-03$$p2004-0252$$r0.00$$u14986$$bMAIN$$10$$kF 191 MEL.I$$v2004-07-16$$zTagged$$71
000013397 980__ $$aBIB
000013397 999__ $$c14102$$d14102